| View |
|
DRP-9038
|
Clonazepam
|
Zepaclon
|
2 mg
|
Tablet
|
Antiepileptic (Benzodiazepine derivative)
|
Remedica Ltd.
|
Cyprus
|
Initial
|
05 November 2021
|
05 November 2026
|
| View |
|
DRP-5969-03
|
Ceftriaxone (As Sodium)
|
Novatrix
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Sance Laboratories Pvt. Ltd.
|
India
|
-
|
18 October 2021
|
29 January 2025
|
| View |
|
DRP-9206-03
|
Ascobic Acid + Zinc
|
Cecor Plus
|
500 mg (equivalent to 562.4 mg Sodium ascorbate)/ 10 mg (equivalent to 27.5 mg Zinc sulfate monohydrate)
|
Capsule
|
-
|
La Croesus Pharma, Inc.
|
Philippines
|
Initial (Reconstruction)
|
12 August 2022
|
12 October 2025
|
| View |
|
DRHR-2080
|
Sulfur
|
None
|
60mg/g (6% w/w)
|
Ointment
|
-
|
Maridan Industries, Inc.
|
Philippines
|
-
|
04 November 2021
|
04 November 2026
|
| View |
|
DRP-4232-02
|
Esomeprazole (As Magnesium Trihydrate)
|
Esolev
|
40 mg
|
Capsule
|
Proton Pump Inhibitor
|
Amegh Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
07 March 2023
|
14 February 2028
|
| View |
|
DRP-7088-02
|
Cefuroxime(As Sodium)
|
Roxxin
|
750mg
|
Powder For Injection (IM/IV)
|
Antibacterial
|
Nitin Lifesciences Ltd.
|
India
|
Automatic Renewal
|
14 March 2022
|
10 March 2027
|
| View |
|
DRP-6839-02
|
Montelukast (As Sodium)
|
None
|
4 mg
|
Chewable Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
26 October 2021
|
30 June 2025
|
| View |
|
DRP-6391-03
|
Doxofylline
|
None
|
400 mg
|
Tablet
|
Bronchodilator
|
Hizon Laboratories, Inc.
|
Philippines
|
Initial
|
26 October 2021
|
03 December 2024
|
| View |
|
DRP-6743-05
|
Rosuvastatin
|
None
|
10 mg
|
Film - Coated Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
26 October 2021
|
30 March 2025
|
| View |
|
BR-1375
|
Bevacizumab
|
Zirabev
|
100 mg/4 mL (25 mg/mL)
|
Concentrate For Solution For I.V. Injection
|
-
|
Pharmacia and Upjohn Company LLC
|
United States of America
|
Initial
|
19 October 2021
|
19 October 2026
|
| View |
|
BR-1376
|
Bevacizumab
|
Zirabev
|
400 mg/16 mL (25 mg/mL)
|
Concentrate For Solution For I.V. Injection
|
-
|
Pharmacia and Upjohn Company LLC
|
United States of America
|
Initial
|
19 October 2021
|
19 October 2026
|
| View |
|
DRP-6741-02
|
Montelukast (As Sodium)
|
None
|
10 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist
|
Hizon Laboratories, Inc.
|
Philippines
|
Initial
|
26 October 2021
|
15 July 2025
|
| View |
|
DRP-3207-05
|
Telmisartan
|
Oratel-80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Theon Pharmaceuticals Limited
|
India
|
Initial
|
24 February 2022
|
24 August 2026
|
| View |
|
DRP-5968-09
|
Hydrocortisone (As Sodium Succinate)
|
Gortizone
|
250 mg
|
Powder for Injection (IM/IV)
|
-
|
Umedica Laboratories Pvt. Ltd.
|
India
|
-
|
22 February 2022
|
29 January 2025
|
| View |
|
DRP-9050-02
|
Dobutamine (As Hydrochloride)
|
Gobutmin
|
50 mg/mL
|
Solution For Intravenous Infusion
|
-
|
BC World Pharm. Co., Ltd.
|
Korea
|
-
|
18 October 2021
|
31 October 2025
|
| View |
|
DRP-8994-05
|
Gliclazide
|
Glimcose
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
02 November 2024
|
14 August 2030
|
| View |
|
DRP-8993-02
|
Gliclazide
|
Glimcose
|
30 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
12 October 2024
|
29 July 2030
|
| View |
|
DRP-2655-29
|
Celecoxib
|
Philicoxib
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
11 June 2023
|
20 December 2028
|
| View |
|
DRP-8994-04
|
Gliclazide
|
Gliclaform
|
60 mg
|
Modified Release Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
18 October 2021
|
14 August 2025
|
| View |
|
DRP-1304-04
|
Mefenamic Acid
|
Auspidol
|
500 mg
|
Capsule
|
Non-steroidal Anti-inflammatory Agent (Non-Selective COX Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
16 February 2022
|
28 February 2027
|